Botulism News and Research

RSS
Botulism is a rare but serious paralytic illness caused by botulinum toxin, which is produced by the bacterium ''Clostridium botulinum''. The toxin enters the body in one of four ways: by colonization of the digestive tract by the bacterium in children (infant botulism) or adults (adult intestinal toxemia), by ingestion of toxin from foodstuffs (foodborne botulism) or by contamination of a wound by the bacterium (wound botulism).
Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists sequence Clostridium botulinum genome that produces neurotoxin

New study identifies recurrent wound botulism among injection drug users

New study identifies recurrent wound botulism among injection drug users

FDA stops operations of N.Y.-based beverage company

FDA stops operations of N.Y.-based beverage company

Clostridium bacteria may offer a greener alternative to petrol

Clostridium bacteria may offer a greener alternative to petrol

Sanofi Pasteur commences phase II clinical study of vaccine for Clostridium difficile infection prevention

Sanofi Pasteur commences phase II clinical study of vaccine for Clostridium difficile infection prevention

Multiple sclerosis drug shows promise to counteract effects of botulinum neurotoxin

Multiple sclerosis drug shows promise to counteract effects of botulinum neurotoxin

University of Padua Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize

University of Padua Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize

Botox receives FDA approval for treatment of chronic migraine

Botox receives FDA approval for treatment of chronic migraine

FDA files complaint for permanent injunction against Brooklyn Juice Company

FDA files complaint for permanent injunction against Brooklyn Juice Company

New method for detecting spores of non-proteolytic Clostridium botulinum

New method for detecting spores of non-proteolytic Clostridium botulinum

Albert Einstein College of Medicine receives grant to study role of proteins in health and disease

Albert Einstein College of Medicine receives grant to study role of proteins in health and disease

Cangene to focus commercialization efforts on key markets

Cangene to focus commercialization efforts on key markets

Neogen fiscal 2010 net income increases 26% to $17.5M

Neogen fiscal 2010 net income increases 26% to $17.5M

Cangene eliminated from ARS contract

Cangene eliminated from ARS contract

Cangene announces development of Immune Globulin Intravenous product

Cangene announces development of Immune Globulin Intravenous product

Cangene third-quarter revenues decline 39% to $41.1M

Cangene third-quarter revenues decline 39% to $41.1M

Botox reduces short-term pain in thoracic outlet syndrome patients

Botox reduces short-term pain in thoracic outlet syndrome patients

SQI Diagnostics second-quarter net loss increases to $2,021,000

SQI Diagnostics second-quarter net loss increases to $2,021,000

The Toronto Stock Exchange accepts Cangene's normal course issuer bid

The Toronto Stock Exchange accepts Cangene's normal course issuer bid

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics signs development agreement with Silliker